AB020. Clinical Significance of PET/CT Maximum Standardized Uptake Value in Predicting Lymph Node Metastasis of Thymic Epithelial Tumors

Jian Gao,Siyang Wang,Yongqiang Ao,Miao Lin,Shuai Wang,Jiahao Jiang,Hongcheng Shi,Jianyong Ding
DOI: https://doi.org/10.21037/med-23-ab020
2023-01-01
Mediastinum
Abstract:Background: The 8th TNM staging system requires the systematic evaluation of mediastinal lymph nodes in thymic epithelial tumors (TETs). In this study, we aimed to explore the clinical impact of PET/CT maximum standardized uptake value (SUVmax) of TETs on predicting lymph node metastasis. Methods: Patients who were diagnosed with TETs from 2015 to 2022 and underwent PET/CT scans were included. Multivariable logistic regression analyses were used to analyze the independent factors differentiating thymoma and thymic carcinoma and predicting lymph node metastasis. Receiver operating curve (ROC) was applied to determine the efficiency and thresholds in distinguishing between thymoma and thymic carcinoma and predicting lymph node metastasis. Results: A total of 124 patients were included. Lymph node metastases were present in 44.1% (15/34) of thymic carcinoma patients, compared with only 1.1% (1/90) of thymoma patients. Based on the factors including age, gender, tumor size, local invasion, myasthenia gravis, CT value, SUVmax, metabolic tumor volume (MTV) and total lesion glycolysis (TLG), the multivariable regression models identified SUVmax as an independent factor for distinguishing thymic carcinoma from thymoma [odd ratio (OR) 1.994, 95% confidence interval (CI): 1.527–2.604, P<0.001] and predicting nodal metastasis of thymic carcinoma (OR 1.462, 95% CI: 1.217–1.756, P<0.001). ROC analysis suggested that SUVmax threshold of 6.17 could distinguish thymic carcinoma from thymoma [area under the curve (AUC): 0.918, sensitivity: 0.882, specificity: 0.789]. In addition, the SUVmax threshold of 10.1 could predict nodal metastasis of thymic carcinoma with the positive predictive value of 0.81 and negative predictive value of 0.97 (AUC: 0.931, sensitivity: 0.812, specificity: 0.972). Conclusions: PET/CT SUVmax is a reliable factor to distinguish thymic carcinoma from thymoma and predict lymph node metastasis of thymic carcinoma. TETs with SUVmax more than 10 need to have systematic nodal dissection in thymectomy.
What problem does this paper attempt to address?